Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion

This statement seeks to guide specialists who provide gonadotoxic therapy and fertility specialists in attempts to preserve fertility and to aid patients in reproducing after gonadotoxic treatment.

Like Comment

Volume 110, Issue 3, Pages 380–386


Ethics Committee of the American Society for Reproductive Medicine


Chemotherapy and radiation therapy often result in reduced fertility. Patients receiving gonadotoxic treatment should be informed of options for fertility preservation and future reproduction prior to such treatment. Reproduction in the context of cancer also raises a number of ethical issues related to the welfare of both patients and offspring. This document replaces the document titled, “Fertility preservation and reproduction in patients facing goandotoxic therapies,” last published in 2013.

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.